Results 91 to 100 of about 1,140,114 (148)

Correction: First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies. [PDF]

open access: yesJ Hematol Oncol
Mahadevan D   +14 more
europepmc   +1 more source

RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine. [PDF]

open access: yesInt J Mol Sci
Focșa IO   +11 more
europepmc   +1 more source

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in <i>BRAF</i> V600-Mutant Advanced Melanoma. [PDF]

open access: yesJ Clin Oncol
Ribas A   +24 more
europepmc   +1 more source

Safety and efficacy of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer in the CodeBreaK 101 phase Ib study. [PDF]

open access: yesESMO Open
Masuishi T   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy